BR0113731A - Comprimidos contendo epinastina produzidos por compressão direta - Google Patents

Comprimidos contendo epinastina produzidos por compressão direta

Info

Publication number
BR0113731A
BR0113731A BR0113731-0A BR0113731A BR0113731A BR 0113731 A BR0113731 A BR 0113731A BR 0113731 A BR0113731 A BR 0113731A BR 0113731 A BR0113731 A BR 0113731A
Authority
BR
Brazil
Prior art keywords
epinastine
direct compression
containing tablets
tablets produced
produced
Prior art date
Application number
BR0113731-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0113731A publication Critical patent/BR0113731A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0113731-0A 2000-09-08 2001-09-04 Comprimidos contendo epinastina produzidos por compressão direta BR0113731A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000315849A JP2002087963A (ja) 2000-09-08 2000-09-08 直接打錠により製造されたエピナスチン含有錠剤
PCT/EP2001/010139 WO2002020018A1 (en) 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression

Publications (1)

Publication Number Publication Date
BR0113731A true BR0113731A (pt) 2003-07-29

Family

ID=18794888

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113731-0A BR0113731A (pt) 2000-09-08 2001-09-04 Comprimidos contendo epinastina produzidos por compressão direta

Country Status (6)

Country Link
JP (1) JP2002087963A (es)
AU (1) AU2001291820A1 (es)
BR (1) BR0113731A (es)
EC (1) ECSP034501A (es)
MX (1) MXPA03002013A (es)
WO (1) WO2002020018A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
JP5291324B2 (ja) * 2007-11-01 2013-09-18 沢井製薬株式会社 口腔内崩壊錠
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
EP1041990B1 (en) * 1997-12-23 2006-06-28 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
EP1000623A1 (en) * 1998-09-29 2000-05-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Use of epinastine as antitussivum
JP4016128B2 (ja) * 1999-09-09 2007-12-05 東和薬品株式会社 耐光性塩酸エピナスチンフィルムコート錠

Also Published As

Publication number Publication date
WO2002020018A8 (en) 2002-09-19
MXPA03002013A (es) 2003-07-24
AU2001291820A1 (en) 2002-03-22
ECSP034501A (es) 2003-04-25
JP2002087963A (ja) 2002-03-27
WO2002020018A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
BR122018068298B8 (pt) processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
BRPI0307702B8 (pt) formulações de solução contendo anticorpo
BR0105899A (pt) Agente cosmético pulverulento e processo para a sua preparação
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
BR0215392A (pt) Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas
MX9303376A (es) Utilizacion de metilhidroxietil- o metilhidroxipropil-(eteres de celulosa)carboximetilados.
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
ES2175825T3 (es) Antitraspirante con dibencilidensorbitol.
BR0012696A (pt) Composição oftálmica
TW200502447A (en) Solid regenerated standard viscose fibre
BR0304218A (pt) ésteres alicìclicos com fragrância de almìscar
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
BR0012553A (pt) Pastilhas contendo ambroxol
BR0110069A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
BR0113731A (pt) Comprimidos contendo epinastina produzidos por compressão direta
BR0316549A (pt) ésteres de ácido carbamìnico com efeito anticolinérgico
UY26494A1 (es) " estabilización de vino"
BR0116077A (pt) Micropartìculas com perfil de liberação aperfeiçoado e processos para produção das mesmas
DE50001659D1 (de) Hartkaramellen mit verbesserter lagerstabilität
ID26858A (id) Proses memproduksi hidrogen peroksida
MXPA02007962A (es) Articulo absorbente.
BR0208553A (pt) Agente de revestimento aquoso transparente com pó de vidro
BR9808537A (pt) Processo para preparação de tabletes de composição detergente, e, tablete.
BR0016141A (pt) Conjunto de recipiente e tampa unitário
ES1047592Y (es) Recuperador de los musculos del cuello.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.